Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Signify Health, Inc. SGFY NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
35/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$27.33
-10.4%

Signify Health, Inc. (SGFY) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $30.49. It has a SharesGrow Score of 35/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Analyst consensus target is SGFY = $27 (-10.4% upside).

Financials: revenue is $806M, +17.5%/yr average growth. Net income is $130M (loss), growing at -399.9%/yr. Net profit margin is -16.2% (negative). Gross margin is 45.3% (-5.4 pp trend).

Balance sheet: total debt is $362M against $627M equity (Debt-to-Equity (D/E) ratio 0.58, moderate). Current ratio is 1.62 (strong liquidity). Debt-to-assets is 20.8%. Total assets: $1.7B.

Analyst outlook: 8 / 14 analysts rate SGFY as buy (57%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 20/100 (Fail), Growth 48/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 48/100 (Partial), Future 28/100 (Fail), Income 10/100 (Fail).

$27.33
▼ 10.36% Downside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Signify Health, Inc., the average price target is $27.33, with a high forecast of $32.00, and a low forecast of $20.00.
Highest Price Target
$32.00
Average Price Target
$27.33
Lowest Price Target
$20.00

SGFY SharesGrow Score Overview

35/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 20/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 48/100
Gross margin is + market cap
FUTURE 28/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SGFY

✗
VALUE Fail
20/100
SGFY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $27, implying -11.4% from the current price $30. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
48/100
SGFY: +17.5%/yr revenue is, -399.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
SGFY: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet SGFY: Debt-to-Equity (D/E) ratio 0.58 (moderate), Current ratio is 1.62 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
48/100
SGFY: Gross margin is 45.3% (-5.4 pp trend), $9B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 48/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
28/100
Analyst outlook: 8 / 14 analysts rate SGFY as buy (57%). Analyst consensus target is $27 (-11.4% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
SGFY: Net profit margin is -16.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range10.7-30.5
Volume9.63M
Avg Volume (30D)2.65M
Market Cap$8.93B
Beta (1Y)0.36
Share Statistics
EPS (TTM)-0.74
Shares Outstanding$176.29M
IPO Date2021-02-11
Employees2,100
CEOBradford Kyle Armbrester
Financial Highlights & Ratios
Revenue (TTM)$805.5M
Gross Profit$365.1M
EBITDA$-27.7M
Net Income$-130.4M
Operating Income$109M
Total Cash$466.1M
Total Debt$362.1M
Net Debt$-104M
Total Assets$1.74B
Price / Earnings (P/E)-41.2
Price / Sales (P/S)11.09
Analyst Forecast
1Y Price Target$30.00
Target High$32.00
Target Low$20.00
Upside-1.6%
Rating ConsensusBuy
Analysts Covering14
Buy 57% Hold 43% Sell 0%
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS82671G1004

Price Chart

Track all markets on TradingView
SGFY
Signify Health, Inc. ↗  ·  NYSE
Healthcare • Medical - Healthcare Information Services
10.70 52WK RANGE 30.50

People Also View

RCM
RCM
R1 RCM Inc.
$14.31
+0.00%
 PRVA
PRVA
Privia Health Group, Inc.
$23.44
+1.38%
 NXGN
NXGN
NextGen Healthcare, Inc.
$23.94
+0.13%
 AGTI
AGTI
Agiliti, Inc.
$10.05
-0.50%
 CERT
CERT
Certara, Inc.
$6.15
+5.67%
 MDRX
MDRX
Veradigm Inc.
$4.20
-6.46%
 HSTM
HSTM
HealthStream, Inc.
$21.04
+3.44%
 PHR
PHR
Phreesia, Inc.
$9.06
+5.35%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message